(Q36721408)

English

Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: Relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases

scientific article published on December 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: Relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases (English)

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

author name string

U. N. Das

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726126

9 November 2022

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 1991

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:095232789190018Z?httpAccept=text/xml

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

https://api.elsevier.com/content/article/PII:095232789190018Z?httpAccept=text/plain

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Prostaglandins, Leukotrienes and Essential Fatty Acids

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

201-210

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Rheumatoid arthritis. Pathophysiology and implications for therapy

1

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials

2

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment

4

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion

6

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Collagenase at Sites of Cartilage Erosion in the Rheumatoid Joint

7

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant

11

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study

12

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Stimulation of neovascularization by human rheumatoid synovial tissue macrophages

14

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Angiogenic factors

15

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

The control of antibody production by immunomodulatory molecules

16

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

17

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction

18

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Diminished IL-2-induced gamma-interferon production by unstimulated peripheral-blood lymphocytes in rheumatoid arthritis

19

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

20

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions

21

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins

22

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Enhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis

23

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions

24

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Collagenolytic Systems in Rheumatoid Arthritis

25

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Transforming growth factor-beta in rheumatoid arthritis

26

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Myosin: a link between streptococci and heart

27

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan

28

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas

29

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis

30

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage

32

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis?

33

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods

35

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

An analysis of the levels of complement components in the synovial fluid in rheumatic diseases

36

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Possible role of free radical altered IgG in the etiopathogenesis of rheumatoid arthritis

39

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Interleukin-1 potentiates the development of collagen-induced arthritis in mice

40

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Agranulocytosis, aplastic anemia, and leukemia: relevance to arachidonic acid metabolism

41

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Activation of neutrophils by recombinant interleukin 6

42

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions

43

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

44

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis

45

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells

46

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon

47

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration

48

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells

49

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Effects of prostaglandins and cAMP levels on monocyte IL-1 production

50

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Arachidonic acid metabolites regulate interleukin-1 production

51

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

53

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids

55

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Tumor necrosis factor provokes superoxide anion generation from neutrophils

57

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent process

58

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

59

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo

60

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism

61

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Characteristics of tumor necrosis factor production in rheumatoid arthritis

63

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Free radicals as possible mediators of the actions of interferon

64

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

65

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

66

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3

67

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Potentiation of immunosuppressive effects of cyclosporin A by 1 alpha,25-dihydroxyvitamin D3.

68

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Some recent advances in the chemistry and biology of transforming growth factor-beta

70

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation

71

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Transcriptional modulation of transin gene expression by epidermal growth factor and transforming growth factor beta

73

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Transforming growth factor beta stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes

74

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Transforming growth factor-beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis

77

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Effect of fish oil supplementation on erythrocyte lipid pattern, malondialdehyde production and glutathione-peroxidase activity in psoriasis

78

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis

80

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid

81

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Dietary fatty acids and inflammatory skin disease

82

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response

83

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study

84

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Correlation of fatty acid composition of adipose tissue lipids and serum phosphatidylcholine and serum concentrations of micronutrients with disease duration in rheumatoid arthritis

85

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Prostaglandins and their precursors can modify genetic damage-induced by gamma-radiation and benzo(a)pyrene

86

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Prostaglandins can modify gamma-radiation and chemical induced cytotoxicity and genetic damage in vitro and in vivo

87

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formation of I and 2 series prostaglandins: relevance to inflammation and immunity

88

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study

90

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study

91

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Non-A, Non-B hepatitis: sorting through a diagnosis of exclusion

92

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

93

1 reference

10.1016/0952-3278(91)90018-Z

https://api.crossref.org/works/10.1016/0952-3278(91)90018-Z

9 November 2022

Identifiers

10.1016/0952-3278(91)90018-Z

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36721408&oldid=1768104965"